This ATRS PE ratio history page last updated 5/12/2022
Period | Price | GAAP | TTM | PE |
Q1 2022 5/10/2022 | 5.56 | -0.01 | 0.07 | 79.4 | Q4 2021 3/3/2022 | 3.80 | 0.02 | 0.10 | 38.0 | Q3 2021 11/4/2021 | 3.66 | 0.03 | 0.11 | 33.3 | Q2 2021 8/5/2021 | 4.23 | 0.03 | 0.11 | 38.5 | Q1 2021 5/6/2021 | 3.60 | 0.02 | 0.09 | 40.0 | Q4 2020 3/2/2021 | 4.06 | 0.03 | 0.06 | 67.7 | Q3 2020 11/5/2020 | 3.05 | 0.03 | 0.06 | 50.8 | Q2 2020 8/6/2020 | 2.89 | 0.01 | 0.04 | 72.2 | Q1 2020 5/5/2020 | 2.74 | -0.01 | 0.02 | 137.0 | Q4 2019 3/3/2020 | 3.11 | 0.03 | 0.00 | NA | Q3 2019 11/5/2019 | 3.70 | 0.01 | 0.01 | 370.0 | Q2 2019 8/6/2019 | 3.28 | -0.01 | -0.01 | NA | Q1 2019 5/2/2019 | 2.98 | -0.03 | -0.03 | NA | Q4 2018 2/28/2019 | 3.59 | 0.04 | -0.04 | NA | Q3 2018 11/6/2018 | 3.61 | -0.01 | -0.10 | NA | Q2 2018 8/7/2018 | 2.89 | -0.03 | -0.12 | NA | Q1 2018 5/8/2018 | 2.44 | -0.04 | -0.11 | NA | Q4 2017 3/13/2018 | 2.66 | -0.02 | -0.10 | NA | Q3 2017 11/7/2017 | 1.79 | -0.03 | -0.11 | NA | Q2 2017 8/8/2017 | 3.14 | -0.02 | -0.12 | NA | Q1 2017 5/9/2017 | 2.79 | -0.03 | -0.14 | NA | Q4 2016 3/14/2017 | 2.59 | -0.03 | -0.16 | NA | Q3 2016 11/9/2016 | 1.79 | -0.04 | -0.17 | NA | Q2 2016 8/9/2016 | 1.15 | -0.04 | -0.17 | NA | Q1 2016 5/9/2016 | 0.91 | -0.05 | -0.14 | NA | Q4 2015 3/8/2016 | 0.92 | -0.04 | -0.14 | NA | Q3 2015 11/5/2015 | 1.33 | -0.04 | -0.18 | NA | Q2 2015 8/10/2015 | 2.09 | -0.01 | -0.19 | NA | Q1 2015 5/11/2015 | 2.20 | -0.05 | -0.25 | NA | Q4 2014 3/12/2015 | 2.68 | -0.08 | -0.27 | NA | Q3 2014 11/6/2014 | 2.15 | -0.05 | -0.23 | NA | Q2 2014 8/7/2014 | 2.04 | -0.07 | -0.23 | NA | Q1 2014 5/9/2014 | 3.06 | -0.07 | -0.20 | NA | Q4 2013 3/13/2014 | 4.02 | -0.04 | -0.16 | NA | Q3 2013 11/6/2013 | 3.72 | -0.05 | -0.16 | NA | Q2 2013 8/7/2013 | 4.58 | -0.04 | NA | NA | Q1 2013 5/8/2013 | 3.74 | -0.03 | NA | NA | Q4 2012 3/13/2013 | 3.45 | -0.04 | NA | NA |
|
Period | Price | GAAP | Annualized | PE |
Q1 2022 5/10/2022 | 5.56 | -0.01 | -0.04 | NA | Q4 2021 3/3/2022 | 3.80 | 0.02 | 0.08 | 47.5 | Q3 2021 11/4/2021 | 3.66 | 0.03 | 0.12 | 30.5 | Q2 2021 8/5/2021 | 4.23 | 0.03 | 0.12 | 35.3 | Q1 2021 5/6/2021 | 3.60 | 0.02 | 0.08 | 45.0 | Q4 2020 3/2/2021 | 4.06 | 0.03 | 0.12 | 33.8 | Q3 2020 11/5/2020 | 3.05 | 0.03 | 0.12 | 25.4 | Q2 2020 8/6/2020 | 2.89 | 0.01 | 0.04 | 72.2 | Q1 2020 5/5/2020 | 2.74 | -0.01 | -0.04 | NA | Q4 2019 3/3/2020 | 3.11 | 0.03 | 0.12 | 25.9 | Q3 2019 11/5/2019 | 3.70 | 0.01 | 0.04 | 92.5 | Q2 2019 8/6/2019 | 3.28 | -0.01 | -0.04 | NA | Q1 2019 5/2/2019 | 2.98 | -0.03 | -0.12 | NA | Q4 2018 2/28/2019 | 3.59 | 0.04 | 0.16 | 22.4 | Q3 2018 11/6/2018 | 3.61 | -0.01 | -0.04 | NA | Q2 2018 8/7/2018 | 2.89 | -0.03 | -0.12 | NA | Q1 2018 5/8/2018 | 2.44 | -0.04 | -0.16 | NA | Q4 2017 3/13/2018 | 2.66 | -0.02 | -0.08 | NA | Q3 2017 11/7/2017 | 1.79 | -0.03 | -0.12 | NA | Q2 2017 8/8/2017 | 3.14 | -0.02 | -0.08 | NA | Q1 2017 5/9/2017 | 2.79 | -0.03 | -0.12 | NA | Q4 2016 3/14/2017 | 2.59 | -0.03 | -0.12 | NA | Q3 2016 11/9/2016 | 1.79 | -0.04 | -0.16 | NA | Q2 2016 8/9/2016 | 1.15 | -0.04 | -0.16 | NA | Q1 2016 5/9/2016 | 0.91 | -0.05 | -0.20 | NA | Q4 2015 3/8/2016 | 0.92 | -0.04 | -0.16 | NA | Q3 2015 11/5/2015 | 1.33 | -0.04 | -0.16 | NA | Q2 2015 8/10/2015 | 2.09 | -0.01 | -0.04 | NA | Q1 2015 5/11/2015 | 2.20 | -0.05 | -0.20 | NA | Q4 2014 3/12/2015 | 2.68 | -0.08 | -0.32 | NA | Q3 2014 11/6/2014 | 2.15 | -0.05 | -0.20 | NA | Q2 2014 8/7/2014 | 2.04 | -0.07 | -0.28 | NA | Q1 2014 5/9/2014 | 3.06 | -0.07 | -0.28 | NA | Q4 2013 3/13/2014 | 4.02 | -0.04 | -0.16 | NA | Q3 2013 11/6/2013 | 3.72 | -0.05 | -0.20 | NA | Q2 2013 8/7/2013 | 4.58 | -0.04 | -0.16 | NA | Q1 2013 5/8/2013 | 3.74 | -0.03 | -0.12 | NA | Q4 2012 3/13/2013 | 3.45 | -0.04 | -0.16 | NA |
|
On this page we presented the ATRS PE Ratio History information for Antares Pharma' stock.
The average ATRS PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 43.0. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average ATRS PE ratio history based on this TTM earnings result method is 92.7. Note: any PE calculations involving negative earnings were discarded as not meaningful.
Let's now compare this ATRS PE ratio history result, against the recent PE: when this page was posted on 5/11/2022, the most recent closing price for ATRS had been 5.56, and the most recent quarterly earnings result, annualized, was 0.08. Meanwhile, the most recent TTM earnings summed to 0.07. From these numbers, we calculate the recent ATRS PE on 5/11/2022 based on annualized quarterly EPS was 69.5. Based on ATRS's history, that recent PE is elevated relative to the historical average, with the recent PE 61.6% higher than the historical average PE across our data set for Antares Pharma. Looking at the recent ATRS PE on 5/11/2022 based on TTM EPS, we calculate the ratio at 79.4. Based on ATRS's history, that recent PE is low relative to the historical average, with the recent PE 14.3% lower than the average PE across our Antares Pharma data set with TTM EPS used in the calculation at each period.
Another interesting ATRS PE ratio history calculation we look at is to take the median earnings per share of the last four quarters for ATRS, and then annualize the resulting value... with that annualized number then being used in the PE calculation. To walk through this math for ATRS, we start with the past four EPS numbers and we first sort them from lowest to highest: -0.01, 0.02, 0.03, and 0.03. We then toss out the highest and lowest result, and then take the average of those two middle numbers — 0.02 and 0.03 — which gives us the median of 0.03. Basically the way to think about this 0.03 number is this: for the trailing four earnings reports, 0.03 marks the "middle ground" number where ATRS has reported a value higher than 0.03 half the time, and has reported a value lower than 0.03 half the time. Annualizing that median value then gets us to 0.12/share, which we use as the denominator in our next PE calculation. With 5.56 as the numerator (as of 5/11/2022), the calculation is then 5.56 / 0.12 = 46.3 as the ATRS PE ratio as of 5/11/2022, based on that annualized median value we calculated.
For self directed investors doing their due diligence on ATRS or any other given stock, valuation analysis for ATRS
can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can
help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios
justify the current stock market value.
That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate
Antares Pharma PE ratio history — or the PE history for any stock in our coverage universe.
And in your continued research we hope you will be sure to check out the further links included for
next earnings dates and also historical earnings surprises history for ATRS. Thanks for visiting, and the next
time you need to research ATRS PE Ratio History or the PE ratio history for another stock, we hope our site
will come to mind as your go-to PE ratio history research resource of choice.